These results, together with a preceding report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,2 assist the notion of concentrating on ACKR3 as a unique strategy to modulate the opioid program, which could open new therapeutic avenues for opioid-linked disorders. Take note: Final results might https://wendellv820ezt6.blogdosaga.com/profile